Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells

Authors Wu S, Zhao X, Cui Z, Zhao C, Wang Y, Du L, Li Y

Received 20 November 2013

Accepted for publication 10 January 2014

Published 14 March 2014 Volume 2014:9(1) Pages 1413—1421

DOI https://doi.org/10.2147/IJN.S57946

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Shaoling Wu,1 Xindong Zhao,2 Zhongguang Cui,1 Chunting Zhao,1 Yuzhen Wang,1 Li Du,1 Yanhui Li3

1Department of Hematology, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong, People's Republic of China; 2Department of Hematology, Medical College of Qingdao University, Qingdao, Shandong, People's Republic of China; 3Laboratory of Fiber Materials and Modern Textile, The Growing Base for State Key Laboratory, Qingdao University, Qingdao, Shandong, People's Republic of China

Abstract: The purpose of this study was to evaluate the cytotoxicity of human multiple myeloma cells (RPMI-8226) treated with graphene oxide (GO), doxorubicin (DOX), and GO loaded with DOX (GO/DOX). Cell viability was determined using the Cell Counting Kit-8 assay and analyzing the cell cycle and cell apoptosis. Cells treated with GO, GO/DOX, and pure DOX for 24 hours showed a decrease in proliferation. GO/DOX significantly inhibited cell proliferation as compared with pure DOX (P<0.01). When the effects of GO were removed, there was no observed difference between GO/DOX and pure DOX (P>0.05). Flow cytometry analysis of untreated and GO-, DOX-, and GO/DOX-treated cells found no significant differences in the G0/G1 phase (P>0.05), while significant differences were observed in the total apoptotic rates (P<0.05). No significant differences existed in the total apoptotic rates of GO-treated and untreated cells (P>0.05). These findings suggest that GO caused low cytotoxicity and did not induce cell apoptosis or change the cell cycle in multiple myeloma cells. Moreover, GO did not affect the antitumor activity of DOX. In conclusion, GO would be suitable as an anticancer drug nanocarrier and used to treat hematological malignancies.

Keywords: graphene oxide, doxorubicin, human multiple myeloma cell, CCK-8, cell cycle, cell apoptosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Biological responses according to the shape and size of carbon nanotubes in BEAS-2B and MESO-1 cells

Haniu H, Saito N, Matsuda Y, Tsukahara T, Usui Y, Maruyama K, Takanashi S, Aoki K, Kobayashi S, Nomura H, Tanaka M, Okamoto M, Kato H

International Journal of Nanomedicine 2014, 9:1979-1990

Published Date: 17 April 2014

Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug

Wang H, Gu W, Xiao N, Ye L, Xu Q

International Journal of Nanomedicine 2014, 9:1433-1442

Published Date: 18 March 2014

Acute toxicity of nickel nanoparticles in rats after intravenous injection

Magaye RR, Yue X, Zou B, Shi H, Yu H, Liu K, Lin X, Xu J, Yang C, Wu A, Zhao J

International Journal of Nanomedicine 2014, 9:1393-1402

Published Date: 12 March 2014

In vivo and in vitro investigations of a nanostructured coating material – a preclinical study

Adam M, Ganz C, Xu W, Sarajian HR, Götz W, Gerber T

International Journal of Nanomedicine 2014, 9:975-984

Published Date: 14 February 2014

Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models

Marianecci C, Rinaldi F, Di Marzio L, Mastriota M, Pieretti S, Celia C, Paolino D, Iannone M, Fresta M, Carafa M

International Journal of Nanomedicine 2014, 9:635-651

Published Date: 24 January 2014

Umbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: application for in vivo cell tracking

Sibov TT, Pavon LF, Miyaki LA, Mamani JB, Nucci LP, Alvarim LT, Silveira PH, Marti LC, Gamarra LF

International Journal of Nanomedicine 2014, 9:337-350

Published Date: 8 January 2014

Development of high drug-loading nanomicelles targeting steroids to the brain

Zheng S, Xie Y, Li Y, Li L, Tian N, Zhu W, Yan G, Wu C, Hu H

International Journal of Nanomedicine 2014, 9:55-66

Published Date: 18 December 2013

Use of electroporation and reverse iontophoresis for extraction of transdermal multibiomarkers

Ching CTS, Fu LS, Sun TP, Hsu TH, Chang KM

International Journal of Nanomedicine 2012, 7:885-894

Published Date: 22 February 2012

Carbon nanotube composites for glucose biosensor incorporated with reverse iontophoresis function for noninvasive glucose monitoring

Tai-Ping Sun, Hsiu-Li Shieh, Congo Tak-Shing Ching, et al

International Journal of Nanomedicine 2010, 5:343-349

Published Date: 4 May 2010